Literature DB >> 10200850

Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study.

F Venturini1, M B Nichol, J C Sung, K L Bailey, M Cody, J S McCombs.   

Abstract

OBJECTIVE: To determine which factors affect compliance with sulfonylureas in a population served by a health maintenance organization in Southern California.
METHODS: Retrospective analysis of pharmacy records and healthcare utilization data for two years (April 1993-March 1995), and a survey mailed to patients. Patients treated with sulfonylureas were selected for analysis on the basis of their prescription profile. Compliance was measured from the pharmacy records as the proportion of days the patient was in possession of the prescribed medications. Patient compliance with sulfonylureas was modeled as a function of four clusters of determinants: patient-related attributes, drug regimen characteristics and complexity, health status and disease-related variables, and characteristics of the interaction with healthcare providers.
RESULTS: 786 patients were identified for analysis (49.1% women, mean age 59 y). The mean compliance rate was 83% +/- 22% SD. Compliance was significantly positively related with age and self-reported level of medication-taking compliance at baseline. Factors shown to have an inverse relationship with compliance were treatment complexity, perception of general health, and being a newly treated patient (adjusted R2 for the final model = 0.148).
CONCLUSIONS: Our results suggest that factors found to be associated with noncompliant behavior (e.g., being a newly treated patient, self-reported compliance, regimen complexity) can be assessed by physicians and pharmacists as a routine practice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10200850     DOI: 10.1345/aph.18198

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  24 in total

Review 1.  Association between medication regimen complexity and pharmacotherapy adherence: a systematic review.

Authors:  Laís Lessa Pantuzza; Maria das Graças Braga Ceccato; Micheline Rosa Silveira; Luane Mendes Ribeiro Junqueira; Adriano Max Moreira Reis
Journal:  Eur J Clin Pharmacol       Date:  2017-08-04       Impact factor: 2.953

2.  The relationship between depressive symptoms and medication nonadherence in type 2 diabetes: the role of social support.

Authors:  Chandra Y Osborn; Leonard E Egede
Journal:  Gen Hosp Psychiatry       Date:  2012-03-07       Impact factor: 3.238

3.  Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy.

Authors:  Giovanni Corrao; Silvana Antonietta Romio; Antonella Zambon; Luca Merlino; Emanuele Bosi; Marina Scavini
Journal:  Eur J Clin Pharmacol       Date:  2010-11-19       Impact factor: 2.953

4.  Predictors of medication adherence in an urban Latino community with healthcare disparities.

Authors:  Jennifer A Colby; Fei Wang; Jyoti Chhabra; Rafael Pérez-Escamilla
Journal:  J Immigr Minor Health       Date:  2012-08

5.  Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit.

Authors:  Benjamin A Toll; Sherry A McKee; Daniel J Martin; Peter Jatlow; Stephanie S O'Malley
Journal:  Nicotine Tob Res       Date:  2007-05       Impact factor: 4.244

6.  How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.

Authors:  Thomas Wilke; Antje Groth; Sabrina Mueller; Dallas Reese; Roland Linder; Susanne Ahrens; Frank Verheyen
Journal:  Eur J Health Econ       Date:  2012-07-20

7.  Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.

Authors:  Marsha A Raebel; Wendy Dyer; Gregory A Nichols; Glenn K Goodrich; Julie A Schmittdiel
Journal:  Pharmacotherapy       Date:  2017-09-12       Impact factor: 4.705

8.  Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes.

Authors:  Anan S Jarab; Reham Almrayat; Salam Alqudah; Ekbal Thehairat; Tareq L Mukattash; Maher Khdour; Sharrel Pinto
Journal:  Int J Clin Pharm       Date:  2014-05-08

9.  Family practice patients' adherence to statin medications.

Authors:  Nandini Natarajan; R Wayne Putnam; Alexandra M Yip; Dawn Frail
Journal:  Can Fam Physician       Date:  2007-12       Impact factor: 3.275

Review 10.  Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.

Authors:  Frieder Bauss; R Graham G Russell
Journal:  Osteoporos Int       Date:  2004-03-26       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.